Sertraline 50 MG

DRUG3 trials

Sponsors

Federico II University, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Tanta University

Conditions

Burning Mouth SyndromeChronic Kidney Disease (CKD)DepressionElderlyOutpatient

Phase 2

Allopurinol in Depression

Not yet recruitingNCT07574060

Tanta UniversityDepression

Start: 2026-05-20End: 2027-05-20Target: 70Updated: 2026-05-07

Phase 3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Federico II UniversityBurning Mouth Syndrome

Start: 2023-01-01End: 2024-07-24Target: 203Updated: 2023-09-06

Unknown Phase

Sertraline and the Risk of Serious Adverse Events

CompletedNCT07387120

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sChronic Kidney Disease (CKD), Elderly, Outpatient

Start: 2008-01-01End: 2026-01-01Updated: 2026-02-04

Related Papers

Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial

Current Neuropharmacology2025-02-283 citations